Lasola, Epefania A.
HRN: 14-60-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2023
CEFTRIAXONE 1G (VIAL)
08/06/2023
08/12/2023
IVT
2gms
Od
T/c Complete Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes